Barcelona, 5th of December 2013.- Almirall announced today a reorganization at European level in...
Around-the-clock symptom relief is vital to the many millions of Chronic Obstructive Pulmonary Disease (COPD) sufferers
Most of the 64 million COPD patients around the world, including over 2 million in Spain, mu...
More Press releases Nuevo
- 11/11/2013 2013/11/11 2013/12/10 Almirall’s Q3: On track to deliver year guidance; Eklira® Genuair® ’s global rollout continues
- 04/11/2013 2013/11/04 2013/12/10 Aclidinium and formoterol fixed dose combination for COPD submitted for registration in Europe
- 11/10/2013 2013/10/11 2013/12/10 Aclidinium, chosen as one of the best Spanish therapeutic innovations with an international reach
- 02/10/2013 2013/10/02 2013/12/10 New data reinforce the efficacy and safety profile of Sativex® in Multiple Sclerosis Spasticity
- 09/09/2013 2013/09/09 2013/12/10 The importance of 24 hours symptom relief for those suffering from COPD